Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am wiling to buy all 325K shares today!
That is what I am thinking. Trying to determine where the price will be after the dilution. They will probably do a reverse spilt at some point to get off the BB exchange. Maybe 100 to 1? Seen this before with nanocap biotechs. But they do it when they think they have news.
Just been doing my due diligence and watching his videos on the website. So in reading the 10K we need $10
Million right?
I like the fact he wants to use RNAi to create vaccines and provide an integrated solution with the diagnostic assays.
That is mine. I want to start building a position in Genethera. When will the secondary offering take place? Thinking there will be big dilution. How long have you been in GTHR?
$6.97 TPIV price target announced by SeeThrough Equity. I believe Glynn is speaking at that conference tomorrow.
Raising money below a dollar is crazy. Dilutes everyone too much including key insiders. That would be dumb.
Key insiders should fund the company with $1 million by buying shares at $5. Refuse to let anyone buy shares below fair value. Do this slow and steady funding as needed until they get some strong news that sends the price high for good. I am willing to wait. Then allow anxious institutional investors to buy in at $7 or $8. We have no debt. No need to raise $20 million with the share price at $2.
I will continue to buy TPIV shares and take advantage of these ridiculous prices. I believe the stock price will be much higher in the years ahead as the clinical trial data is released. My hope is that the promising Phase 1 data is strongly confirmed by future Phase 2 results.
Then they should have closed it in mid March because now it is a disaster with the biotech meltdown. I still suspect manipulation. Financially desperate companies have to give the company away to lucky people who have the cash they need. They drive the price down and steal the company. This sets me back to the Dec low prices. Still believe in the science but the timing disappoints. Poor planning but who knew Biotech was on the cusp of getting whacked in March. This company has had the worst luck over the last 13 years. I feel sorry for original GeneMax investors if any are left. If there are, they are probably in psychotherapy.
Maybe the folks participating in the next capital raise are the ones manipulating the price down so they can steal cheap shares. Everybody's a crook these days. Thought we had momentum and were beyond this manipulation crap. Will just take longer than I thought to make money from this investment.
We need real news for the stock to move. We just don't have anything new to report now. Great opportunity for short selling manipulators to drive it down on this criminal crap exchange called the OTC. We need news on licensing something for real money that is non dilutive. Have to stop paying our bills with cheap shares.
If these short seller idiots ever get breast cancer they will curse why biotech companies can't get treatments commercialized quicker. Hope they never have to rue the day when they hindered a company that could have saved their lives.
The SEC needs a separate agency to police this piece of crap exchange where manipulation runs rampant. It is a disgrace to American equity markets. Safer to buy stocks in a third world country than this piece of crap!
The SEC needs a separate agency to monitor this piece of crap exchange called the OTC.
Manipulation is probably why insiders have not purchased shares. They know the evil short sellers will pillage this poor company trying to save lives until we get out of the pit of this crappy exchange we are traded on. Maybe God will let this poor company survive all the evil people trying to destroy it.
Back to manipulation by hedge funds looking to destroy a promising company. Thought we were done with this illegal activity. Nobody cares about OTC stocks do it continues and we have all been set back another year.
I don't know for sure but probably sometime in 2015. Maybe we will hear more next time they issue an update.
I have been buying during the recent price weakness and will continue to buy regularly over the next several years. I anticipate having to pay a higher price for shares in the future than I can today!
I will hold TapImmune stock for at least 10 years! I think they are going to achieve great things combining Keith Knutson's groundbreaking research with their PolyStart and TAP technologies. Perfect fit for becoming an immunotherapy leader with a multi billion dollar market cap eventually. It only takes a few positive Phase 2 results to send a biotech stock price soaring. I will wait for that to happen.
When will they post the video from the Corporate Roadshow on YouTube? Last year there were interviews with Glynn Wilson and Keith Knutson. They were interviewed by Dana from that company.
Very interesting. Once we get this financing done the price will rise.
I agree with your analysis.
I have not been called. How did they get your number?
Our TAP and PolyStart combined with Knutson's epitope discoveries Will
Be Unrivaled Vaccines that break new ground.
Triple Negative Breast Cancer is an Orphan Disease and will be huge as there are no safe and effective treatments for this horrible scourge. Keith Knutson should get a Nobel Prize if he cures breast cancer!
Dr. Keith Knutson is chairman of the Scientific Advisory Board as of March 19, 2014 per the new annual report. Google Keith Knutson and the Artemis project and "Breast Cancer 2020". He is personally motivated to cure cancer by Jan. 1 2020 with a preventative cancer vaccine. Great guy for Glynn Wilson to have a great working relationship with. Hope we commercialize all his discoveries.
Don't raise capital now, we missed our opportunity at $5.50. Better wait now until the next news story and better market conditions. Or just focus on non dulitive sources of cash. What's another month or two? Some have been waiting since 2002.
What makes you think we are not buying when scared little
rabbits are selling? By the way, are you a scared rabbit selling? What is your interest in TPIV? Are you a short seller basher for some institution hoping to get shares cheap or are you holding shares of a TPIV competitor that will get crushed over the next few years?
I don't think most people understand the science that Glynn Wilson is trying to describe in these releases. It is very technical and takes some imagination and vision to truly see how TapImmume could revolutionize vaccines. He also needs to build awareness on Walll Street because the share price was so crazy low for years that it went under the radar for most institutional investors. But now we start the uptrend that will last for 20 years as they create many first in class, superior treatments for hard to treat diseases. A wealth creation machine is being built before our eyes.
Nice PR today. 5 times greater tumor killing for the TPIV vaccine versus Neuvax. Billions and billions in potential revenue. $2B for the smallpox stockpile in the past and we know we can make a smallpox vaccine 1000 times better. We have superior technology! It is so obvious to me that TPIV will probably have a future market cap in the tens of billions. It just takes time to get the clinical data compiled. This stock is so undervalued now it is stealing buying shares under $50.
Yes I meant $7 and the TPIV price will be $70 over the next 3 years when positive Phase 2 data starts rolling in. Just takes time and most investors are not visionary and will wait to buy until the data is released.
Down 50% from the $7 high from two weeks ago. Predictable given the lack of news over the last week. Short term investors have weak faith and are impatient. News on non dilutive sources of cash might get it moving for good.
We need news of non dilutive cash received for a partnership to get the stock going for good. Get the cash without issuing more stock. That would cause the price to soar.
Regen shares are in my Schwab accounts.
I think Regen will be worth billions in market cap when their 2 drugs are a success. Min and Ichim are brilliant scientists who have carefully created DCellVax and HemaXellerate based on excellent research. Then with the other 28 patents they focus on who knows how many successful drugs for rare diseases they will create. I will hold my BMSN ENTB and Regen shares for 20 years and make millions from a modest investment.
TPIV's TAP and PolyStart plus the new epitopes and future epitopes from the relationship
with Keith Knutson will revolutionize care for breast, ovarian and skin cancer. So much good news ahead of us over the next 5 years. I don't think anyone knows how large Tapimmune can become. Alexion has
1 successful product and they are valued at around $30 billion. If Tapimmune has 3 successful
vaccines, especially a breast cancer vaccine that addresses a larger population than Herceptin, what will we be valued at? $50 billion might be a low estimate 5 years from now.
Nice job market maker manipulator! I congratulated you too soon! Really great manipulation this afternoon!
Nice market manipulation today walking it down before Glynn Wilson speaks tomorrow at noon. Who in their right mind would sell now with all the momentum gaining with TapImmune's groundbreaking technology?
Either uninformed traders or market manipulation today. Who would sell TPIV at these ridiculous prices given the news we had yesterday? Can't wait until this company has a $10 billion market cap.